| Product Code: ETC7625744 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Despite a high Herfindahl-Hirschman Index (HHI) indicating concentrated market share, Ireland saw a decline in carcinoembryonic antigen import shipments in 2024. The top exporting countries, including the USA, UK, and Germany, continue to dominate the market. However, with a negative Compound Annual Growth Rate (CAGR) of -4.18% from 2020 to 2024 and a significant decline of -30.16% in growth rate from 2023 to 2024, the Irish market for carcinoembryonic antigen imports faced challenges and a downward trend in recent years.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Carcinoembryonic Antigen Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Carcinoembryonic Antigen Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland Carcinoembryonic Antigen Market - Industry Life Cycle |
3.4 Ireland Carcinoembryonic Antigen Market - Porter's Five Forces |
3.5 Ireland Carcinoembryonic Antigen Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Ireland Carcinoembryonic Antigen Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Ireland |
4.2.2 Growing awareness about early cancer detection and screening |
4.2.3 Technological advancements in CEA testing methods |
4.3 Market Restraints |
4.3.1 Stringent regulations and approval processes for new CEA testing products |
4.3.2 Limited reimbursement policies for CEA testing in Ireland |
5 Ireland Carcinoembryonic Antigen Market Trends |
6 Ireland Carcinoembryonic Antigen Market, By Types |
6.1 Ireland Carcinoembryonic Antigen Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 Ireland Carcinoembryonic Antigen Market Revenues & Volume, By Application, 2021- 2031F |
6.1.3 Ireland Carcinoembryonic Antigen Market Revenues & Volume, By Colorectal Cancer, 2021- 2031F |
6.1.4 Ireland Carcinoembryonic Antigen Market Revenues & Volume, By Pancreatic Cancer, 2021- 2031F |
6.1.5 Ireland Carcinoembryonic Antigen Market Revenues & Volume, By Ovarian Cancer, 2021- 2031F |
6.1.6 Ireland Carcinoembryonic Antigen Market Revenues & Volume, By Breast Cancer, 2021- 2031F |
6.1.7 Ireland Carcinoembryonic Antigen Market Revenues & Volume, By Thyroid Cancer, 2021- 2031F |
6.1.8 Ireland Carcinoembryonic Antigen Market Revenues & Volume, By Others, 2021- 2031F |
7 Ireland Carcinoembryonic Antigen Market Import-Export Trade Statistics |
7.1 Ireland Carcinoembryonic Antigen Market Export to Major Countries |
7.2 Ireland Carcinoembryonic Antigen Market Imports from Major Countries |
8 Ireland Carcinoembryonic Antigen Market Key Performance Indicators |
8.1 Adoption rate of CEA testing in Ireland |
8.2 Number of healthcare facilities offering CEA testing services |
8.3 Investment in research and development for CEA testing technologies |
9 Ireland Carcinoembryonic Antigen Market - Opportunity Assessment |
9.1 Ireland Carcinoembryonic Antigen Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Ireland Carcinoembryonic Antigen Market - Competitive Landscape |
10.1 Ireland Carcinoembryonic Antigen Market Revenue Share, By Companies, 2024 |
10.2 Ireland Carcinoembryonic Antigen Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |